Multidisciplinary Real-World Experience With Bilastine, a Second Generation Antihistamine

February 2020 | Volume 19 | Issue 2 | Original Article | 145 | Copyright © February 2020

Published online February 11, 2020

Charles W. Lynde MD FRCPC,^a Gordon Sussman MD FRCPC,^b Pierre-Luc Dion MD FRCPC,^c Lyn Guenther MD FRCPC,^d Jacques Hébert MD FRCPC,^e Jaggi Rao MD FRCPC,^f Tim Vander Leek MD FRCPC FAAAAI,^g Susan Waserman MSc FRCPC^h

^aDepartment of Medicine, University of Toronto, Toronto, ON, Canada ^bDivision of Allergy/Clinical Immunology, University of Toronto, Toronto, ON, Canada ^cDivision of Dermatology, Université Laval, Québec, Québec, Canada; CISSS de Chaudière-Appalaches – Hôtel-Dieu de Lévis, Lévis, Québec, Canada ^dWestern University, London, ON. Royal College of Physicians and Surgeons of Canada, ^eDepartment of Medicine, Université Laval, Québec, Canada ^fDivision of Dermatology, University of Alberta, Edmonton, Alberta, Canada ^gDepartment of Pediatrics, Stollery Children’s Hospital, University of Alberta, Edmonton, Alberta, Canada ^hDivision of Clinical Immunology & Allergy, Department of Medicine, McMaster University, Hamilton, ON, Canada